Serum interleukin-17 and estradiol levels in postmenopausal women in relation to osteoporosis

Egyptian Rheumatology and Rehabilitation

Table 4 Correlation study between IL-17, E2, radiological data, and different studied variables in postmenopausal women

	Estrogen		IL-17		DEXA score		FRAX
	r	P value	r	P value	r	P value	r	P value
Age (years)	−0.407*	0.026	0.254	0.176	−0.232	0.217	0.584**	0.001
Duration of menopause	−0.394*	0.031	0.212	0.262	−0.193	0.308	0.553**	0.002
BMI	0.192	0.309	−0.100	0.598	0.083	0.663	−0.298	0.110
ADL	0.164	0.387	−0.121	0.523	0.069	0.716	−0.051	0.790
ESR	0.076	0.690	−0.259	0.166	0.236	0.209	−0.109	0.568
CRP	−0.014	0.940	−0.051	0.790	−0.075	0.693	−0.066	0.728
PTH	−0.004	0.982	−0.157	0.407	−0.007	0.969	−0.163	0.389

P value ≤ 0.05, non-significant; P value ≤ 0.05, significant; P value ≤ 0.01, highly significant
r Spearman correlation coefficient, BMI body mass index, ADL activities of daily living, ESR erythrocyte sedimentation rate, CRP C-reactive protein, PTH parathyroid hormone, IL-17 interleukin-17, DEXA dual energy X-ray absorptiometry, FRAX fracture risk assessment tool